Brian C. Monk

Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix: A phase II study of the Gynecologic Oncology GroupBrewer CA, Blessing JA, Nagourney RA, et al (Univ of California, Orange; Univ of Mississippi, Jackson; Roswell Park Cancer Inst, Buffalo, NY; et al) Gynecol Oncol 100:385–388, 2006§

Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18Villa LL, Ault KA, Giuliano AR, et al (Ludwig Inst for Cancer Research, Sao Paulo, SP, Brazil; Univ of Iowa, Iowa City; Univ of Arizona, Tucson; et al) Vaccine 24:5571–5583, 2006§

A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: Follow-up of a Gynecologic Oncology Group studyRotman M, Sedlis A, Piedmonte MR, et al (SUNY Downstate Med Ctr, Brooklyn, NY; Roswell Park Cancer Inst, Buffalo, NY; Wake Forest Univ, Winston-Salem, NC; et al) Int J Radiat Oncol Biol Phys 65:169–176, 2006§

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trialHarper DM, for the HPV Vaccine Study group (Dartmouth Med School, Lebanon, NH; et al) Lancet 367:1247–1255, 2006§

Utilization of Diagnostic Studies in the Pretreatment Evaluation of Invasive Cervical Cancer in the United States: Results of Intergroup Protocol ACRIN 6651/GOG 183Amendola MA, Hricak H, Mitchell DG, et al (Univ of Miami, Fla; Mem Sloan-Kettering Cancer Ctr, New York; Thomas Jefferson Univ, Philadelphia; et al) J Clin Oncol 23:7454–7459, 2005§

Human Papillomavirus Testing and Liquid-Based Cytology: Results at Recruitment From the New Technologies for Cervical Cancer Randomized Controlled TrialRonco G, for the New Technologies for Cervical Cancer Working Group (Centro per la Prevenzione Oncologica, Turin, Italy; et al) J Natl Cancer Inst 98:765–774, 2006§

Quality of Life Outcomes From a Randomized Phase III Trial of Cisplatin With or Without Topotecan in Advanced Carcinoma of the Cervix: A Gynecologic Oncology Group StudyMonk BJ, Huang HQ, Cella D, et al (Univ of California, Orange; Roswell Park Cancer Inst, Buffalo, NY; Northwestern Univ, Evanston, III; et al) J Clin Oncol 23:4617–4625, 2005§

Gene Expression Profiling of in Vitro Radiation Resistance in Cervical Carcinoma: A Feasibility StudyTewari D, Monk BJ, Al-Ghazi MS, et al (Univ of California, Orange; Oncotech, Inc, Irvine, Calif) Gynecol Oncol 99:84–91, 2005§

Vaccines Against Human Papillomavirus and Cervical Cancer: Promises and ChallengesMahdavi A, Monk BJ (Univ of California, Orange) Oncologist 10:528–538, 2005§

Laparoscopically Assisted Radical Vaginal Hysterectomy vs Radical Abdominal Hysterectomy for Cervical Cancer: A Match Controlled StudyJackson KS, Das N, Naik R, et al (Queen Elizabeth Hosp, Gateshead, England) Gynecol Oncol 95:655–661, 2004§